Quince Therapeutics, Inc. short interest in 2026
In 2026, Quince Therapeutics, Inc.'s disclosed short interest ran from 6.20% of shares outstanding on 15 Jan 2026 to 4.94% on 15 Sep 2026, a change of -1.26 percentage points. The year's high was 6.20% on 15 Jan 2026 and its low 0.03% on 15 Jul 2026, averaging 3.73% across 7 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.30 days on 15 Jan 2026. Full history: Quince Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 6.20% (15 Jan 2026)
- End of year
- 4.94% (15 Sep 2026)
- Change
- -1.26 pp
- High
- 6.20% (15 Jan 2026)
- Low
- 0.03% (15 Jul 2026)
- Average
- 3.73%
- Highest days to cover
- 3.30 (15 Jan 2026)
- SEC filings marked
- 5
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 6.20% | 3.30 | |
| 30 Jan 2026 | 3.37% | 1.00 | |
| 15 Jul 2026 | 0.03% | 1.18 | results (8-K), 10-K filed, 10-Q filed |
| 31 Jul 2026 | 0.03% | 1.52 | |
| 14 Aug 2026 | 5.93% | 1.73 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 5.60% | 2.66 | |
| 15 Sep 2026 | 4.94% | 3.00 |
See also: Quince Therapeutics, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.